Delivery Order SPE2DR25D2013-SPE2DR26F5QNR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,015.03 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count packaging) with a firm fixed price structure. This non-set-aside, competitively awarded contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication used primarily for...
- The Defense Logistics Agency awarded a $9,283.93 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on July 25, 2025, with completion targeted for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Carvedilol is a beta-blocker used to treat heart failure and hypertension, representing routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,923.82 to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $22,717.96 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 80 mg capsules (30-count units). This contract employs firm fixed-price terms with an ultimate completion date of August 20, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $10,979.56 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units). This competitive award, issued on November 4, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 5, 2025. The contract is non-set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Carvedilol ER 80 mg capsules (30-count units) with a ceiling value of $16,575.44. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, represents a direct purchase under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be supplied from the vendor's corporate office location...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) under a non-competitive, non-set-aside contract. The award, valued at $3,994.69, was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,453.54 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Carvedilol ER 80 mg capsules (30-count units) with a ceiling value of $28,539.05. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for completion by November 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $9,299.57. This competitively awarded, firm fixed-price delivery order was executed on October 30, 2025, with an ultimate completion date of October 31, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order operates under...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5QNRDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count) with a ceiling value of $1,366.76. The award, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a non-set-aside competitive award to the vendor's Corporate Office located in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication used primarily for managing hypertension and heart failure, indicating this delivery supports the federal medical supply chain serving military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of pharmaceutical and medical supply deliveries across multiple therapeutic domains. The company's consistent selection for competitive federal awards demonstrates its capability to meet stringent procurement requirements for military healthcare operations and related federal medical programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/18/25 |